Effects of Nintedanib in an Animal Model of Liver Fibrosis

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

(2019) Oliver Distler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice

(2019) Warinda Susutlertpanya et al.   LIFE SCIENCES

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

(2019) Kevin R. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gastrointestinal and Hepatic Disease in Systemic Sclerosis

(2018) Tracy M. Frech et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Systemic sclerosis

(2017) Christopher P Denton et al.   LANCET

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

(2017) Nicole S. Goh et al.   Arthritis & Rheumatology

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model

(2017) Büsra Öztürk Akcora et al.   Scientific Reports

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

(2016) Luca Richeldi et al.   RESPIRATORY MEDICINE

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

(2016) Veronika K. Jaeger et al.   PLoS One

Interstitial lung disease in children

(2014) Christin S. Kuo et al.   CURRENT OPINION IN PEDIATRICS

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Invariant natural killer T-cell-deficient mice display increased CCl4-induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration

(2011) Mariette Lisbonne et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

(2011) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

(2008) F. Hilberg et al.   CANCER RESEARCH